HOLD, not a new-money entry at the reference price. Pricing offsets fewer cases, but aluminum and operating costs reduce profit. Cash flow benefits from timing. Our three-route base is $28.50 with high uncertainty; a conditional entry requires about $21.38 plus operating and liquidity tests.
Profitable franchise, uncertain recovery; analyst scenarios at the August 1 financial anchor.
| Item | Value |
|---|---|
| Bear | 20.000 |
| Base | 28.500 |
| Bull | 43.000 |
| Probability weighted | 28.850 |
| Reference price | 30.910 |
| Scenario | Probability | 12-month value | vs $30.91 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 30% | $20.00 | −35% | FY2028 sales $1.10 B, 14.5% margin; persistent demand / input pressure. | 16× after-tax operating profit at FY2028 end + scenario interim cash; raw $20.117→$20. |
| Base | 50% | $28.50 | −8% | FY2028 sales $1.2036 B, 18% margin; gradual recovery. | 50/30/20 DCF/economic earnings/revenue routes; raw $28.32991→$28.50. |
| Bull | 20% | $43.00 | +39% | FY2028 sales $1.28 B, 21% margin; demand and input cost recovery. | 21.25× after-tax operating profit at FY2028 end + scenario interim cash; raw $42.936→$43. |
| Weighted value = 30%×$20 +50%×$28.50 +20%×$43 =$28.85. Range is not a guaranteed price boundary. | |||||
| Signpost | Now (Q1 FY2027) | Green if | Red if | Next check |
|---|---|---|---|---|
| Case volume YoY | −6.4% | Better than −3% | Worse than −8% | By Dec 15,2026 |
| Gross margin | 35.0% | At least 36% | Below 33.5% | By Dec 15,2026 |
| Quarter-end cash | $107.098 M | At least $75 M | Below $50 M unexplained | By Dec 15,2026 |
| Funded borrowing | $0 | Remains $0 | Above $25 M | By Dec 15,2026 |
| Gross common model | 94 M | At or below 94 M | Above 95 M | By Dec 15,2026 |
| Fiscal capex | Q1 $3.071 M | Near prior FY $25.142 M | Above $35 M without returns | By July 15,2027 |
Dates are analytical review deadlines except the separately stated annual meeting. Thresholds are ours, not guidance. Price alone cannot satisfy the entry conditions.
National Beverage’s financial story has changed since the earlier special-dividend episode. The present question is whether the business can protect profit while consumers buy fewer cases and aluminum becomes more expensive. The reference price of $30.91 is the September 10 regular-session close. It precedes the current financial filing, so the day’s 1.21% advance is not a measured reaction to this quarter. The available later quotation has a wide bid and ask without a verified executed trade; taking its midpoint would manufacture a market verdict. We keep the regular close as a clearly dated comparison and leave the post-print reaction unavailable.
Our HOLD is a decision to wait for better evidence or a lower valuation, not an invitation to commit new money at that price. The $28.50 base value is below the reference price, and the $28.85 probability-weighted estimate offers little compensation for uncertainty. Three out of five conviction means the accounting and business economics are clear enough to form a view, while the persistence of volume pressure and commodity inflation remains uncertain. Existing holders should assess exposure against their circumstances.
The chart uses unadjusted share prices, not dividend-inclusive total returns. National Beverage’s special distributions materially change the amount of cash retained inside the company and can create mechanical price changes. A price decline alone therefore does not measure the owner’s complete return. Historical filing-window changes below are close-to-next-close observations around the identified financial filing, not isolated causal estimates of an earnings surprise. Some press releases may have had different clocks; we do not relabel those observations as exact release reactions.
| Date | Close |
|---|---|
| 2024-09-30 | $46.94 |
| 2024-10-31 | $45.19 |
| 2024-11-29 | $49.39 |
| 2024-12-31 | $42.67 |
| 2025-01-31 | $42.05 |
| 2025-02-28 | $39.83 |
| 2025-03-31 | $41.54 |
| 2025-04-30 | $44.40 |
| 2025-05-30 | $45.23 |
| 2025-06-30 | $43.24 |
| 2025-07-31 | $45.82 |
| 2025-08-29 | $42.05 |
| 2025-09-30 | $36.92 |
| 2025-10-31 | $34.27 |
| 2025-11-28 | $34.06 |
| 2025-12-31 | $31.89 |
| 2026-01-30 | $34.08 |
| 2026-02-27 | $36.35 |
| 2026-03-31 | $33.65 |
| 2026-04-30 | $34.22 |
| 2026-05-29 | $36.99 |
| 2026-06-30 | $31.20 |
| 2026-07-31 | $31.64 |
| 2026-08-31 | $31.63 |
| 2026-09-10 | $30.91 |
| Period | Next-close change |
|---|---|
| Q1 / 25 | 0.446 |
| Q2 / 25 | −6.538 |
| Q3 / 25 | −1.065 |
| Q4 / 25 | 4.593 |
| Q1 / 26 | −2.900 |
| Q2 / 26 | −3.175 |
| Q3 / 26 | 4.321 |
| Q4 / 26 | 7.516 |
| Not a precise release-response study. Current quarter post-filing next close is unavailable. | |
First-quarter fiscal 2027 net sales were $330.662 million, essentially unchanged from $330.515 million. That apparent stability masks two opposing forces: average selling price per case increased 7.1%, while case volume declined 6.4%. Management says both its Power+ portfolio and carbonated soft-drink brands were affected. The company does not disclose enough brand-level detail to attribute the whole decline to LaCroix, and the aggregate pricing measure should not be treated as a pure same-product list-price increase.
Gross profit declined to $115.790 million from $125.463 million. Operating income fell to $58.480 million from $70.776 million because selling, general and administrative spending also increased. Net income was $47.004 million, compared with $55.760 million, and diluted earnings per share fell from $0.60 to $0.50. The principal deterioration occurred in the operating business. Higher other income and lower absolute tax expense softened the decline; they did not restore the lost operating profit.
Cost of sales per case increased 12.4%, exceeding the reported increase in selling price. Gross margin fell to 35.0% from 38.0%. Management attributes approximately 600 basis points of negative gross-margin pressure to aluminum. This is a contribution to the bridge, not the net margin decline: other factors, including pricing and the remaining cost mix, offset part of it. Subtracting another six percentage points from the reported margin would count the aluminum damage twice. Nor do we simply add all six points back in valuation as though cheaper cans were assured.
A reliable beat-or-miss statement requires a dated, comparable consensus snapshot from before the release. That evidence is unavailable here. The saved annual estimate feed contains one analyst per forecast row, but its revision timestamp and accounting basis are not established. The quarterly endpoint was unavailable. We therefore compare the actual print with prior reported results and our explicit assumptions, without inventing a consensus surprise. Management provided no formal numerical revenue or earnings guidance in the current filing; its capital-spending comment is narrower and is discussed separately.
| USD millions, except EPS | Q1 FY2027 | Q1 FY2026 | YoY | Q4 FY2026* |
|---|---|---|---|---|
| Revenue | 330.662 | 330.515 | +0.0% | 297.120 |
| Gross profit | 115.790 | 125.463 | −7.7% | 103.009 |
| SG&A | 57.310 | 54.687 | +4.8% | 52.867 |
| Operating profit | 58.480 | 70.776 | −17.4% | 50.142 |
| Other income | 3.184 | 2.237 | +42.3% | 2.776 |
| Pretax | 61.664 | 73.013 | −15.5% | 52.918 |
| Income tax | 14.660 | 17.253 | −15.0% | 12.602 |
| Net income | 47.004 | 55.760 | −15.7% | 40.316 |
| Diluted EPS | 0.500 | 0.600 | −16.7% | 0.430 |
| *Q4 derived from annual minus 9 M; EPS uses inferred weighted shares. Sequential summer comparison is seasonal. | ||||
| Period | Revenue |
|---|---|
| Q1 / 25 | 329.473 |
| Q2 / 25 | 291.202 |
| Q3 / 25 | 267.050 |
| Q4 / 25 | 313.629 |
| Q1 / 26 | 330.515 |
| Q2 / 26 | 288.331 |
| Q3 / 26 | 264.586 |
| Q4 / 26 | 297.120 |
| Q1 / 27 | 330.662 |
| FY2025 Q4 has 14 weeks; other quarters 13 weeks. No invented week normalization. | |
National Beverage reports one operating and reportable segment. Its consolidated revenue and operating profit are therefore the segment totals. LaCroix sparkling water, Clear Fruit, Rip It, Everfresh, Mr. Pure, Shasta and Faygo serve different consumer occasions, but the filing does not provide a revenue or profit split that would support a branded sum-of-parts valuation. The charts deliberately show the disclosed consolidated economics and pricing-volume indicators. An invented LaCroix margin would create apparent precision without evidence.
The business combines owned production facilities with warehouse and direct-store delivery. Warehouse delivery lets retailers collect or receive products through their distribution centers; direct-store delivery serves outlets more directly. The channels span take-home, convenience and food service. This structure offers control over formulas, production quality and distribution costs, but it does not insulate the company from retailers’ shelf-space decisions, promotional demands or competition from larger beverage groups and private-label products. Customer concentration percentages were not located in the reviewed annual disclosure and are not estimated from general knowledge of grocery retailing.
Shipping and handling costs are reported in selling, general and administrative expense. They were $20.7 million this quarter, compared with $19.8 million, while marketing rose to $14.4 million from $13.6 million. A competitor that puts freight in cost of sales can report a lower gross margin without having worse final economics. Operating profit is therefore the more comparable starting point for valuation. The disclosed shipping and marketing figures are rounded; subtracting them from total SG&A gives an analytical residual, not a newly disclosed cost category.
The volume trend matters beyond this quarter’s revenue. A brand can raise prices successfully for a time, yet persistent unit losses can weaken utilization, retailer support and the economics of marketing. The bullish interpretation is that consumers are temporarily constrained and the company has preserved its premium positioning. The bearish interpretation is that value competition and price increases have become a structural demand problem. Two quarters of narrowing volume declines would be more persuasive than another flat-revenue headline created solely through pricing.
| Period | Q1 FY2027 YoY |
|---|---|
| Price/case | 7.100 |
| Case volume | −6.400 |
| Cost/case | 12.400 |
| Aggregate company indicators. Brand-level mix and profit are not disclosed. | |
| Period | Operating income |
|---|---|
| Q1 / 25 | 69.515 |
| Q2 / 25 | 57.867 |
| Q3 / 25 | 50.577 |
| Q4 / 25 | 57.500 |
| Q1 / 26 | 70.776 |
| Q2 / 26 | 58.046 |
| Q3 / 26 | 51.146 |
| Q4 / 26 | 50.142 |
| Q1 / 27 | 58.480 |
| Consolidated results equal the sole reported segment; no invented brand split. | |
| Period | Q1 FY2026 | Q1 FY2027 |
|---|---|---|
| Shipping | 19.800 | 20.700 |
| Marketing | 13.600 | 14.400 |
| Other SG&A* | 21.287 | 22.210 |
| Shipping/marketing are rounded issuer disclosures. Other SG&A is an analytical residual including CMA fee; not a reported segment. | ||
The current profit bridge starts with GAAP operating income, not a company-adjusted measure. There is no issuer non-GAAP earnings reconciliation in the reviewed current financial filing. Revenue less cost of sales produces gross profit; gross profit less SG&A produces operating income; other income and tax then lead to net income. There is no disclosed minority allocation in these statements. We do not label a missing reconciliation as a zero adjustment or manufacture adjusted EBITDA simply because another issuer reports one.
Other income, net, was $3.184 million, up from $2.237 million. Management describes approximately $3.3 million of interest income this quarter and $2.2 million a year earlier. Those narrative amounts are rounded and do not separately reconcile every component of the net line. Our economic-earnings route excludes the entire other-income line and values after-tax operating profit, then adds modeled available cash once. Capitalizing interest income and separately adding the bank balance would otherwise give the same cash two values.
Aluminum hedges are part of the operating cost story. The company reclassified $6.578 million of pretax gains from accumulated other comprehensive income into cost of sales this quarter, versus $5.104 million a year earlier. The benefit is already embedded in reported gross profit. Separately, new pretax losses recognized in accumulated other comprehensive income were $7.660 million. Combined with reclassification and taxes, that produces a $10.878 million decline in accumulated other comprehensive income. These are distinct stages of hedge accounting, not two interchangeable measures of cash loss.
At quarter-end, the company had $108.2 million of aluminum swap notional exposure. Assuming unchanged commodity prices, it expected only $2.3 million of existing unrealized pretax gain to reach earnings over the following twelve months, compared with $16.0 million anticipated at the fiscal-year-end snapshot. This is a conditional estimate of gains already on the balance sheet, not a forecast of total future hedge performance or a limit on new contracts. The contrast nevertheless warns against extrapolating the unusually large $31.291 million of hedge gains released during fiscal 2026. Our recovery case requires improved operating economics; it does not assume that prior hedge support automatically repeats.
| Bridge | USD M |
|---|---|
| Operating profit | 58.480 |
| Other income | 3.184 |
| Pretax income | 61.664 |
| Tax expense | −14.660 |
| Net income | 47.004 |
| Period | Pretax gain / loss |
|---|---|
| FY2024 | −10.805 |
| FY2025 | 5.887 |
| FY2026 | 31.291 |
| Already included in GAAP gross profit; do not add again. Current Q1 gain 6.578 M is not an annual forecast. | |
The first-quarter cash result looks stronger than the income result, but the explanation is timing. Operating cash flow increased to $64.850 million from $59.089 million even as net income declined. Current cash flow includes $16.392 million from prepaid and other assets and $6.287 million from accrued and other liabilities. Receivables, inventory and payables consumed cash. The complete cash-flow statement reconciles these movements, noncash expenses and net income; no residual is hidden in an invented cash-quality adjustment.
Cash income taxes were only $0.234 million versus $14.660 million of income-tax expense. Low first-quarter tax payments also occurred in the comparison period. That seasonal pattern is a reason to examine annual cash conversion, not to conclude that the accounting tax charge has disappeared. The opening $4.517 million income-tax payable is recognized separately in our valuation bridge. Future modeled operating earnings bear a normalized 24% cash-tax assumption. The prior liability is deducted once and is not charged again to the remaining-year forecast.
Reported free cash flow, defined here as operating cash flow minus cash purchases of property and equipment, was $61.779 million. Capital expenditure was just $3.071 million in this summer quarter, while management expects fiscal 2027 spending to be comparable to fiscal 2026’s $25.142 million. Multiplying the quarter’s free cash flow by four would ignore both tax timing and the remaining investment program. The trailing four-quarter total of $161.897 million provides a more balanced historical reference, although it too includes working-capital movements and hedge settlements.
The scorecard retains stock compensation as an economic cost. It is small here: $0.087 million this quarter and $0.439 million in fiscal 2026. Low SBC improves the common-holder picture, but it does not eliminate governance risk. The recurring management agreement with a company owned by the chief executive charges one percent of consolidated sales. That expense remains in every modeled operating margin. Receivable and inventory days below use period-end balances and a 91-day quarter consistently; they are analytical indicators, not claims about a separately audited collection schedule. A deterioration in inventory alongside weak cases would deserve more attention than a single quarter of high cash conversion.
| Period | Operating cash | Cash capex | Free cash flow |
|---|---|---|---|
| FY2024 | 197.907 | 30.300 | 167.607 |
| FY2025 | 206.696 | 36.281 | 170.415 |
| FY2026 | 181.254 | 25.142 | 156.112 |
| Reported CFO less cash capex. FY2025 has 53 weeks. | |||
| Period | Receivable days | Inventory days |
|---|---|---|
| Q1 / 25 | 32.047 | 39.834 |
| Q2 / 25 | 31.126 | 45.561 |
| Q3 / 25 | 30.976 | 46.032 |
| Q4 / 25 | 32.546 | 41.616 |
| Q1 / 26 | 29.324 | 41.679 |
| Q2 / 26 | 29.401 | 48.698 |
| Q3 / 26 | 33.510 | 53.009 |
| Q4 / 26 | 31.945 | 44.780 |
| Q1 / 27 | 29.108 | 42.539 |
| Consistent period-end-balance method; seasonal, not average-balance issuer ratios. | ||
| Current cash-flow bridge | USD M |
|---|---|
| Net Income | 47.004 |
| D&A | 6.322 |
| Lease Noncash | 3.945 |
| Deferred Tax | 0.594 |
| SBC | 0.087 |
| Other Noncash | 0.329 |
| Receivables | −1.466 |
| Inventories | −4.924 |
| Prepaid Other Assets | 16.392 |
| Payables | −5.647 |
| Accrued Other Liabilities | 6.287 |
| Lease Liabilities | −4.073 |
| Operating cash flow | 64.850 |
| Cash capex | −3.071 |
| Free cash flow | 61.779 |
| Exact primary cash-flow rows; signed movements, no fabricated normalization. | |
Quarter-end cash was $107.098 million. The balance sheet has no funded borrowings under the disclosed facilities, but that does not make every dollar freely distributable without operating consequences. The company paid $304.249 million of special dividends during the quarter. Starting with $349.543 million of cash, adding operating cash flow, subtracting capital expenditure and the dividend, then adding $0.025 million from option exercises reproduces the ending cash exactly. The distribution is a completed reduction in the cash anchor, not a second cash benefit to add to today’s valuation.
The company has $150 million of revolving facilities, with $2.7 million reserved for standby letters of credit. Available borrowing capacity is a liquidity resource, not an asset that belongs in enterprise-to-equity arithmetic. Operating lease liabilities total $58.771 million. Our models retain rental expense in operating costs and do not also subtract the full operating-lease liability as if the business were valued before rent. This consistent treatment differs from finance debt. Remaining fiscal 2027 contractual operating-lease payments are $12.819 million, and the annual filing also discloses plant-equipment and raw-material purchase commitments.
We retain an analyst operating-cash reserve of $50 million and deduct the existing $4.517 million income-tax payable, leaving $52.581 million added to operating business value. The reserve is a modeling choice, not a reported restriction on cash. It represents roughly seventeen days of the current quarter’s cost of sales and SG&A and sits below the $77.040 million quarter-end cash balance seen after a prior special distribution. Sensitivities show reserves from zero to $75 million, so readers can see how much this judgment changes value. Forecast capital spending and rent remain operating cash uses; the reserve does not create another expense in the model.
Common shares outstanding are 93.615302 million. The annual option count was 0.221800 million before the current quarter’s 0.003200 million disclosed exercises. That limited roll-forward suggests about 93.833902 million gross potential shares, but it is not a certified current option reconciliation. We use a round 94 million gross modeling denominator, credit no exercise proceeds and show alternatives. The 150,000 issued Series C preferred shares are all held in treasury; they are not an outside preferred claim. Unissued award authorizations are not automatically outstanding dilution. Potential multi-employer pension withdrawal liabilities are discussed as unquantified risks rather than invented funded debt.
| Period | Cash |
|---|---|
| Q1 / 25 | 77.040 |
| Q2 / 25 | 112.837 |
| Q3 / 25 | 149.222 |
| Q4 / 25 | 193.835 |
| Q1 / 26 | 249.831 |
| Q2 / 26 | 269.314 |
| Q3 / 26 | 313.973 |
| Q4 / 26 | 349.543 |
| Q1 / 27 | 107.098 |
| Special distributions reduce company cash; do not add past dividends to current value. | |
| Item | Value |
|---|---|
| Gross cash | 107.098 |
| Operating reserve | 50.000 |
| Existing tax payable | 4.517 |
| Cash added to value | 52.581 |
| Common and potential claims | Million shares / USD |
|---|---|
| Issued common | 102.009414 M |
| Treasury common | 8.394112 M |
| Outstanding common | 93.615302 M |
| Annual options, May 2 | 0.221800 M |
| Q1 exercises | 0.003200 M |
| Illustrative gross after exercises | 93.833902 M |
| Model denominator | 94 M |
| Option weighted strike, May 2 | $26.22 |
| Outside Series C preferred | None; all 150,000 issuedshares in treasury |
| Mixed-date options roll-forward is illustrative; no exercise proceeds, no automatic grant of unused authorizations. | |
All valuation cash flows begin at the August 1 financial anchor, after the reported first quarter and dividend. The later September 10 market price is a comparison, not a claim that we possess an updated September balance sheet. We use approximate fiscal-year fractions of 0.75 for the remaining three quarters and 1.75, 2.75, 3.75 and 4.75 for fiscal 2028 through fiscal 2031. We do not count the already-realized first-quarter cash flow again, fabricate cash generated between August and September, or annualize the summer quarter.
Our base fiscal 2027 assumptions are $1.180 billion of sales and $205 million of operating profit. Subtracting the actual quarter leaves $849.338 million of sales and $146.520 million of operating profit for the remaining year. That remaining operating profit is below the prior year’s comparable $159.334 million. The model therefore allows ongoing pressure rather than presuming an immediate rebound. Fiscal 2028 sales grow two percent to $1.2036 billion with an 18% operating margin. Later sales grow three percent annually, and margins reach 18.75% and then 19%. Lower input pressure and less negative volume must earn that recovery; it is not management guidance.
The discounted-cash-flow route applies a 9.5% nominal discount rate, 2.5% terminal growth and 24% normalized tax. It retains stock compensation and the management fee in operating costs, budgets capital expenditure and incremental working capital, and includes no automatic release of working capital in the remaining-year period. The economic-earnings route values fiscal 2028 after-tax operating profit at nineteen times. The revenue route values fiscal 2028 sales at 2.5 times, equivalent to about 13.9 times operating profit at the modeled 18% margin. These multiples are explicit analyst choices, not a claim about a measured peer median.
Both multiple routes are exit-value approaches at fiscal 2028 year-end. Each includes the present value of cash generated before that exit as well as the discounted terminal business value. Omitting the interim cash would make them inconsistent with the DCF. All three routes then add the same cash bridge and divide by the same share assumption. Their 50%, 30% and 20% weights produce an unrounded $28.329910 per share, displayed as $28.50 to the nearest half dollar. The DCF is lower than the multiple routes, which explains why our blended value falls below a price that the earnings route alone can nearly support.
The conditional reverse calculation holds interim cash flows and the nineteen-times exit multiple fixed. On those assumptions, the price requires about a 17.64% fiscal 2028 operating margin, compared with our 18% case. This is not a full reverse DCF and does not prove that the stock is cheap: the DCF assigns a lower value to the cash-flow duration and terminal economics. High uncertainty calls for a 25% margin of safety before a new-money entry. Exact arithmetic gives $21.375, displayed as $21.38; after rounding the discount is approximately 25%. A lower price still requires operating and liquidity conditions to hold.
Operating enterprise value $2,355.549 M + opening modeled cash $52.581 M, divided by 94 M shares. Weight 50%. Explicit future FCFF and terminal value; 9.5% discount /2.5% growth.
Operating enterprise value $2,906.057 M + opening modeled cash $52.581 M, divided by 94 M shares. Weight 30%. FY2028 exit PV $2,668.991 M plus interim FCFF PV $237.066 M.
Operating enterprise value $2,804.193 M + opening modeled cash $52.581 M, divided by 94 M shares. Weight 20%. FY2028 exit PV $2,567.128 M plus interim FCFF PV $237.066 M.
| Period | Years | Sales | EBIT | D&A | Capex | NWC use | FCFF |
|---|---|---|---|---|---|---|---|
| FY2027 remaining Q2–Q4 | 0.75 | 849.338 | 146.520 | 18.678 | 22.071 | 0.000 | 107.962 |
| FY2028 | 1.75 | 1,203.600 | 216.648 | 25.000 | 27.000 | 3.000 | 159.652 |
| FY2029 | 2.75 | 1,239.708 | 232.445 | 26.000 | 29.000 | 3.000 | 170.658 |
| FY2030 | 3.75 | 1,276.899 | 242.611 | 27.000 | 30.000 | 4.000 | 177.384 |
| FY2031 | 4.75 | 1,315.206 | 249.889 | 28.000 | 31.000 | 4.000 | 182.916 |
| USD millions. Remaining FY2027 excludes actual Q1. 24% normalized tax; no automatic working-capital release. | |||||||
| Period | FCFF |
|---|---|
| FY27 Q2–Q4 | 107.962 |
| FY2028 | 159.652 |
| FY2029 | 170.658 |
| FY2030 | 177.384 |
| FY2031 | 182.916 |
| Analyst forecast; first leg only three quarters. Other legs are full fiscal years. | |
| Discount / growth | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|
| 8.5% | $26.42 | $28.00 | $29.84 | $32.01 |
| 9.5% | $23.15 | $24.30 | $25.62 | $27.14 |
| 10.5% | $20.60 | $21.47 | $22.46 | $23.57 |
| 11.5% | $18.56 | $19.24 | $20.00 | $20.84 |
| Share assumption | Reserve $0 M | $25 M | $50 M | $75 M |
|---|---|---|---|---|
| 93.615302 M | $28.98 | $28.71 | $28.45 | $28.18 |
| 93.833902 M | $28.91 | $28.65 | $28.38 | $28.11 |
| 94 M | $28.86 | $28.60 | $28.33 | $28.06 |
| 95 M | $28.56 | $28.29 | $28.03 | $27.77 |
| Unrounded three-route values; existing 4.517 M tax payable deducted in every cell. | ||||
The most recent saved target item is UBS at $32, dated September 4, 2026, accompanied by a maintained Sell grade in the provider’s ratings history. That is before the current financial filing. It is useful context for prior expectations, not evidence of a Wall Street response to this quarter. The saved target path also shows earlier UBS values of $33, $34 and $35. Multiple reports by the same firm are not additional independent analysts.
An aggregate feed labels the consensus Sell and lists eight ratings, split between two buys, two holds and four sells. The aggregate does not provide a sufficiently clear as-of date or current contributor identity. Separately, the target summary collapses to $32 across its reported range. Combining those two feeds as though eight analysts had freshly agreed on one target would overstate the evidence. We show the dated UBS record as dated provider evidence and label the aggregate undated and unverified as a current panel.
The explicit comparison is therefore limited: UBS’s pre-print rating is Sell with a $32 target; Charged Alpha’s current analytical call is HOLD, three out of five conviction, with $28.50 base fair value and high uncertainty. The labels differ even though our numerical value is lower. Rating systems have different horizons and thresholds, and we cannot reconstruct UBS’s full thesis from a headline. Our HOLD means wait rather than buy at the reference price; our preferred entry requires a substantial discount and business tests. A new dated analyst note after the print could update this comparison without changing the primary-source accounting.
| Comparison | Wall Street: dated provider record | Charged Alpha |
|---|---|---|
| Rating | UBS Sell, September 4 before print | HOLD · 3/5 |
| Target / fair value | $32 pre-print target | $28.50 base / $28.85 weighted |
| Alignment | Different rating labels and methods | Both warrant caution; no new-money entry at reference |
| No claim of a fresh eight-analyst target consensus. | ||
| Period | Provider-reported target |
|---|---|
| 2025-12-05 | 35.000 |
| 2026-03-10 | 34.000 |
| 2026-06-26 | 33.000 |
| 2026-09-04 | 32.000 |
| All displayed targets predate the current print. Repeated reports from one firm are not independent analysts. | |
| Fiscal-period estimate | Revenue $M | EBIT $M | EPS | Analysts |
|---|---|---|---|---|
| 2029-05-02 | 1,248.736 | 266.962 | $2.18 | 1 |
| 2028-05-02 | 1,240.805 | 251.715 | $2.05 | 1 |
| 2027-05-02 | 1,232.930 | 238.694 | $1.95 | 1 |
| Provider snapshot date/accounting basis not established; no beat/miss comparison. | ||||
Capital allocation is central to this company, but the dividend is not the operating thesis. The completed distribution returned a large amount of accumulated cash while leaving the business without funded borrowings. That can reward owners and prevent indefinite cash accumulation. It also reduces the margin for operational surprises. We assess the remaining liquidity and future cash generation rather than counting the past payment as a continuing yield or assuming another payment on a fixed schedule.
The latest proxy identifies Nick A. Caporella as beneficial owner of 73.2% of common shares and officers and directors as a group at 74.7%, including the stated beneficial-ownership conventions. Each common share carries one vote. Control is therefore concentrated through ownership of the common class, not a fabricated dual-class share structure. The Nasdaq controlled-company exemptions and the recurring management agreement make board oversight, succession and minority-holder treatment important. High insider ownership may align economic interests, but it also limits outside holders’ practical influence.
Corporate Management Advisors, owned by the chairman and chief executive, receives an annual base fee equal to one percent of consolidated sales. The annual filing describes senior management and administrative services under this arrangement. The fee is not removed from our operating forecast merely because it is related-party spending; those services and that payment are part of the business owners actually receive. We would ask the board how it evaluates value for money, succession capacity and incentives when sales can remain flat through pricing while unit demand weakens.
| Area | Evidence | Assessment |
|---|---|---|
| Volume / pricing | Cases −6.4%; price/case +7.1% | Revenue held; demand unresolved |
| Cost discipline | Gross margin 35%; SG&A 17.3% | Operating margin pressure |
| Capital allocation | 304.249 M dividend; 107.098 M cash | Return complete; preserve liquidity |
| Governance | Nick 73.2%; CMA 1% of sales | Concentrated control and recurring related-party fee |
| Guidance | No numeric sales/EPS guide | Do not assign an invented success rate |
| Audit | Grant Thornton latest; effective ICFR opinion | Accounting assurance, not forecast validation |
The highest operating risk is a persistent mismatch between price increases and consumer demand. A temporary volume decline is manageable for a profitable, debt-free manufacturer; a prolonged decline can affect factory utilization, retailer support and the return on marketing. Our bear case combines lower sales, a 14.5% fiscal 2028 operating margin and a lower valuation multiple. It is not a liquidation scenario. It represents a still-profitable franchise whose growth and pricing power deserve less confidence.
Commodity risk is closely related but not identical. Aluminum, packaging, ingredients and fuel can move independently of consumer demand. Hedges mitigate some exposure, yet the company does not disclose a simple constant hedge ratio that makes future gross margin predictable. Notional contracts are not cash in the bank. A recovery in commodity prices could help, but new tariffs, supply disruptions or more expensive replacement hedges could delay it. The declining existing unrealized gain is a warning about support already accumulated, not proof of the next quarter’s ultimate hedge result.
Governance and succession are material because ownership and leadership are concentrated. The annual filing lists a long-serving leadership team, and the latest proxy confirms control. The presence of independent audit oversight does not erase the minority-holder tradeoff. Operational risks also include labor agreements, manufacturing interruptions, product quality, cyber incidents and competition from much larger beverage businesses. A multi-employer pension plan is in red-zone status with a surcharge; the potential withdrawal liability is not quantified and is not assigned a fabricated dollar deduction.
The strongest bull case is straightforward: consumers stabilize, pricing holds, input pressure eases and the owned production network converts recovery into profit. Our bull case reaches a 21% fiscal 2028 margin on $1.280 billion of sales, with a higher earnings multiple and scenario-specific interim cash. It produces approximately $43 per share. The bear case produces about $20. These rounded scenario values, weighted 30%, 50% and 20%, yield $28.85. They are judgments about uncertain paths, not calibrated probabilities or an assertion that outcomes cannot fall outside the range. We would reconsider trimming above $35 without better operating evidence, and reconsider the HOLD sooner if the demand, margin or cash tests fail.
| Risk | Likelihood | Impact | Test |
|---|---|---|---|
| Persistent volume erosion | High | High | Cases below −8% |
| Input/hedge pressure | High | High | Gross margin below 33.5% |
| Concentrated control/succession | Medium | High | Disclosure, governance, continuity |
| Cash timing / distributions | Medium | Medium | Unexplained cash below 50 M |
| Retail competition | High | Medium | Distribution and promotions |
| Pension/labor obligations | Medium | Medium | Bargaining / unquantified withdrawal exposure |
The next check is the fiscal 2027 second-quarter filing. We use December 15, 2026 as an analytical review deadline, not a confirmed earnings-release date. A volume decline narrower than three percent would support stabilization; a decline worse than eight percent would contradict it. Gross margin at or above 36% would be constructive, while below 33.5% would suggest that pricing and hedging are failing to absorb costs. These are analyst thresholds, not company forecasts.
Cash should be assessed after the normal tax and investment cycle, not immediately after another large distribution or unusual timing movement without explanation. We use $75 million as a constructive quarter-end liquidity threshold and $50 million as an adverse threshold when no new distribution explains the change. A new borrowing balance above $25 million would trigger a review of the previously debt-free investment case. Neither threshold declares an automatic covenant breach; each is a reason to inspect the actual cash bridge and obligations.
The October 2 annual meeting offers a nearer governance checkpoint. The October 18 expiration of the disclosed Central States bargaining agreement is another operating date to monitor; an expiration does not establish that a disruption will occur. The longer-dated credit-facility maturities in 2027 and 2028 are also visible, although no funded borrowing currently needs refinancing. Routine extensions on acceptable terms would preserve flexibility; expensive or restrictive changes would matter more if cash generation weakens.
We will judge the thesis through these disclosed numbers rather than through a promised calendar of price catalysts. Favorable commodity prices can improve gross margin without proving demand recovery, and a temporary inventory reduction can improve cash flow without restoring earnings power. The combined evidence is what changes fair value. If volumes stabilize while the operating margin recovers and common claims remain near the modeled denominator, the valuation can rise even before the preferred entry price arrives. If fundamentals weaken, a cheaper share price may still offer no margin of safety.
| Date | Event | What to check |
|---|---|---|
| October 2, 2026 | Annual meeting scheduled | Capital allocation and succession |
| October 18, 2026 | Disclosed CSSS agreement expiry | Renewal terms; no assumed stoppage |
| By December 15, 2026 | Analytical next-quarter review deadline | Volume, grossmargin, cash; not confirmed print date |
| FY2027 remaining year | Capital investment | Spending comparable to prior 25.142 M per management comment |
| 2027–2028 | Undrawn facility maturities | Terms and liquidity if cash weakens |
The historical tables cover nine quarters from the first quarter of fiscal 2025 through the first quarter of fiscal 2027, plus fiscal 2024, 2025 and 2026 annual statements. Current and historical primary filings are retained with exact source URLs and SHA256 hashes. SEC companyfacts assists extraction, but the filing row headers determine the fiscal period and statement meaning. Annual and nine-month figures are used to derive fourth-quarter flows; they are explicitly identified as calculations, not relabeled annual rows.
Fiscal 2025 contained 53 weeks, including a 14-week fourth quarter. Fiscal 2024 and fiscal 2026 contained 52 weeks. We show the reported history without inventing a comparable-week normalization. Fourth-quarter weighted shares are inferred from annual and nine-month weighted averages using the respective week counts. Dividing derived quarter net income by those shares provides an analytical EPS approximation; it should not be confused with a separately reported quarterly issuer EPS. Cash-flow quarters after the first are differences between year-to-date statements, with the calculation preserved.
Margins divide the relevant profit by revenue. Free cash flow is operating cash flow less purchases of property, plant and equipment and is not itself a GAAP statement line. Receivable and inventory days use closing balances and the same period-length convention; alternative average-balance methods would differ. Economic earnings means after-tax operating income with stock compensation and the recurring management fee retained. The valuation excludes nonoperating interest income and adds the selected opening cash once. Enterprise values and cash-flow measures retain operating rent; lease liabilities are displayed as commitments, not inconsistently removed a second time.
| Quarter | Revenue | COGS | SG&A | EBIT | Other | Tax | NI |
|---|---|---|---|---|---|---|---|
| Q1 FY2025 | 329.473 | 207.041 | 52.917 | 69.515 | 4.347 | 17.082 | 56.780 |
| Q2 FY2025 | 291.202 | 181.851 | 51.484 | 57.867 | 1.729 | 13.959 | 45.637 |
| Q3 FY2025 | 267.050 | 168.100 | 48.373 | 50.577 | 1.398 | 12.332 | 39.643 |
| Q4 FY2025 | 313.629 | 200.421 | 55.708 | 57.500 | 1.631 | 14.370 | 44.761 |
| Q1 FY2026 | 330.515 | 205.052 | 54.687 | 70.776 | 2.237 | 17.253 | 55.760 |
| Q2 FY2026 | 288.331 | 179.146 | 51.139 | 58.046 | 2.655 | 14.337 | 46.364 |
| Q3 FY2026 | 264.586 | 164.982 | 48.458 | 51.146 | 2.793 | 12.731 | 41.208 |
| Q4 FY2026 | 297.120 | 194.111 | 52.867 | 50.142 | 2.776 | 12.602 | 40.316 |
| Q1 FY2027 | 330.662 | 214.872 | 57.310 | 58.480 | 3.184 | 14.660 | 47.004 |
| USD millions; Q4 flows computed from annual minus 9 M. Source links below. | |||||||
| Quarter | Cash | AR | Inventory | Equity | CFO | Capex | FCF |
|---|---|---|---|---|---|---|---|
| Q1 FY2025 | 77.040 | 116.029 | 90.629 | 306.596 | 57.499 | 3.704 | 53.795 |
| Q2 FY2025 | 112.837 | 99.605 | 91.048 | 360.144 | 42.591 | 6.907 | 35.684 |
| Q3 FY2025 | 149.222 | 90.903 | 85.032 | 400.236 | 46.531 | 10.204 | 36.327 |
| Q4 FY2025 | 193.835 | 104.157 | 85.109 | 443.999 | 60.075 | 15.466 | 44.609 |
| Q1 FY2026 | 249.831 | 106.504 | 93.916 | 504.133 | 59.089 | 3.095 | 55.994 |
| Q2 FY2026 | 269.314 | 93.157 | 95.869 | 551.259 | 25.712 | 5.807 | 19.905 |
| Q3 FY2026 | 313.973 | 97.431 | 96.104 | 591.062 | 50.925 | 6.296 | 44.629 |
| Q4 FY2026 | 349.543 | 104.301 | 95.520 | 635.714 | 45.528 | 9.944 | 35.584 |
| Q1 FY2027 | 107.098 | 105.767 | 100.444 | 367.703 | 64.850 | 3.071 | 61.779 |
| USD millions; quarterly cashflows derive from YTD differences where required. | |||||||
| Fiscal year | Weeks | Revenue | EBIT | NI | CFO | Capex | SBC |
|---|---|---|---|---|---|---|---|
| FY2024 | 52 | 1,191.694 | 218.510 | 176.732 | 197.907 | 30.300 | 0.881 |
| FY2025 | 53 | 1,201.354 | 235.459 | 186.821 | 206.696 | 36.281 | 0.606 |
| FY2026 | 52 | 1,180.552 | 230.110 | 183.648 | 181.254 | 25.142 | 0.439 |
| Fiscal year | FCF | Dividends | Buybacks | Cash taxes | Employees |
|---|---|---|---|---|---|
| FY2024 | 167.607 | 0.000 | 0.000 | 55.971 | 1559 |
| FY2025 | 170.415 | 304.148 | 0.000 | 55.993 | 1681 |
| FY2026 | 156.112 | 0.000 | 0.673 | 58.431 | 1677 |
| Employee counts from each annual human-capital section; all annual figures in USD millions except employees. | |||||
| Primary document | Fiscal end | Source |
|---|---|---|
| 10-Q | 2026-08-01 | fizz20260801_10q.htm |
| 10-K | 2026-05-02 | fizz20260502_10k.htm |
| 10-Q | 2026-01-31 | fizz20260125_10q.htm |
| 10-Q | 2025-11-01 | fizz20251025_10q.htm |
| 10-Q | 2025-08-02 | fizz20250802_10q.htm |
| 10-K | 2025-05-03 | fizz20250503_10k.htm |
| 10-Q | 2025-01-25 | fizz20250125_10q.htm |
| 10-Q | 2024-10-26 | fizz20240930_10q.htm |
| 10-Q | 2024-07-27 | fizz20240727_10q.htm |
| 10-K | 2024-04-27 | fizz20240430_10k.htm |
| 10-Q | 2024-01-27 | fizz20240127_10q.htm |
| 10-Q | 2023-10-28 | fizz20231028_10q.htm |
| 10-Q | 2023-07-29 | fizz20230729_10q.htm |
| 10-K | 2023-04-29 | fizz20230429_10k.htm |
| Companyfacts | See source | CIK0000069891.json |
| DEF 14 A | See source | fizz20260820_def14a.htm |
| Exact source SHA256/fetch ledger retained in SOURCES.md and source_ledger.json. Market data: FMP, with dated limitations. | ||